HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles M Conway Selected Research

Monoclonal Antibodies

9/2020Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine.
1/2020Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charles M Conway Research Topics

Disease

14Migraine Disorders (Migraine)
01/2021 - 08/2008
5Neuralgia (Stump Neuralgia)
06/2023 - 11/2013
5Pain (Aches)
06/2023 - 01/2016
2Acute Pain
06/2023 - 01/2016
2Hyperalgesia
01/2017 - 01/2016
1Nausea
01/2019
1Urinary Tract Infections (Urinary Tract Infection)
01/2019
1Inflammation (Inflammations)
01/2017
1Peripheral Nervous System Diseases (PNS Diseases)
01/2016
1Diabetic Neuropathies (Diabetic Neuropathy)
11/2013

Drug/Important Bio-Agent (IBA)

11Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
01/2021 - 04/2012
9Calcitonin Gene-Related PeptideIBA
01/2021 - 08/2008
5rimegepant sulfateIBA
01/2021 - 01/2019
5Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
01/2021 - 08/2008
4Phosphotransferases (Kinase)IBA
06/2023 - 01/2016
3Formaldehyde (Formol)FDA Link
06/2023 - 11/2013
2erenumabIBA
09/2020 - 01/2020
2Monoclonal AntibodiesIBA
09/2020 - 01/2020
24- (8- fluoro- 2- oxo- 1,2- dihydroquinazolin- 3(4H)- yl)- N- (3- (7- methyl- 1H- indazol- 5- yl)- 1- oxo- 1- (4- (piperidin- 1- yl)piperidin- 1- yl)propan- 2- yl)piperidine- 1- carboxamideIBA
04/2012 - 08/2008
1Proteins (Proteins, Gene)FDA Link
06/2023
1TriazinesIBA
06/2023
1EthersIBA
01/2022
1AminesIBA
01/2022
1LigandsIBA
09/2020
1galcanezumabIBA
09/2020
1fremanezumabIBA
09/2020
1TabletsIBA
01/2019
1gamma-Aminobutyric Acid (GABA)IBA
01/2017
1Glycine Receptors (Glycine Receptor)IBA
01/2017
1Amino AcidsFDA Link
01/2017
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2017
1NeuropeptidesIBA
02/2016
1Streptozocin (Streptozotocin)FDA Link
01/2016
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2016
1piperidineIBA
12/2012
1pyridineIBA
04/2012
1AmidesIBA
04/2012
1BMS-846372IBA
04/2012

Therapy/Procedure

2Therapeutics
01/2020 - 01/2020
1Ligation
01/2016